Release form and composition
Dosage form - eye drops 4%: colorless transparent liquid (5 and 10 ml in polymer dropper bottles, 1 or 2 bottles in a cardboard box; 1.5, 2 and 5 ml in polymer dropper tubes, 1, 2, 4, 5 or 10 tubes in a cardboard pack; 5 ml in glass bottles, in a cardboard pack 1 bottle complete with a dropper cap or 5 bottles in a blister pack, in a cardboard pack 1 package complete with 5 dropper caps).
Active substance: taurine, 40 mg in 1 ml of solution.
Additional components: injection water, methyl parahydroxybenzoate, 1 M sodium hydroxide solution to pH 5.0.
Description, composition of Taufon
Taufon is an eye drop that contains vitamins and a sulfur-containing amino acid in the form of taurine, which is formed in the body during the conversion of another amino acid, cysteine.
The medicine improves energy levels, stimulates restoration and healing processes in diseases associated with metabolic disorders. As a sulfur-containing amino acid, taufon helps normalize the function of the body's cell membranes and improves energy and metabolic processes inside the cell. The medicinal properties of the drug are due to the regulation of metabolism at the cellular level.
The effectiveness of the drug is confirmed by positive reviews from many patients.
Directions for use and dosage
Taufon is used in the form of instillations.
For dystrophic diseases and injuries of the cornea, 1-2 drops are prescribed 2-4 times a day for 1 month.
For cataracts, 1-2 drops are prescribed 2-4 times a day for 3 months, after 3 months a repeat course is given.
For open-angle glaucoma, the recommended dose is 1-2 drops 2 times a day for 6 weeks, after which a 2-week break is taken. Taufon is used in combination with timolol or butylaminohydroxypropoxyphenoxymethyl methyloxadiazole and its combined forms, dripped approximately 15–20 minutes before one of the beta-blockers.
Indications for use of Taufon
The medicine is used for various eye diseases that are caused by metabolic disorders (dystrophic lesions of the retina, cornea, various types of cataracts - radiation, traumatic, senile, etc.), traumatic damage to the cornea.
For oral administration (in tablet form), Taufon is prescribed for cardiovascular failure, in case of overdose of cardiac glycosides (drugs of digitalis, lily of the valley, etc.). It is rarely used in this form, because There are more effective metabolic drugs that can replace Taufon when administered systemically.
Indications for use of Taufon drops
From the scope of action, we can say that I use Taufon for a number of diseases, among which are:
- redinodystrophy (dystrophic phenomena on the retina), caused by a number of reasons;
- corneal damage caused by traumatic factors, incl. and domestic injuries;
- cataracts of various etymologies;
- corneal dystrophies caused by senile, traumatic, radiation, and other factors;
- open-angle forms of glaucoma.
Taufon
Another domestic product where the main substance is taurine is Taufon. Taurine is made from the amino acid cysteine, which has two main functions:
- Formation of tissues.
- Launching processes to destroy toxins.
In addition to taurine, the drops contain methylparaben (bactericidal substance), sodium hydroxide (NaOH, regulates the pH environment), purified water (sterile, microbiologically pure solution, tasteless and odorless).
Taufon is contraindicated for children under 18 years of age and people with allergies to its components. Ophthalmologists recommend drops for the following diseases:
- Corneal dystrophy.
- Cataract (age-related, traumatic).
- Glaucoma (in complex therapy).
- Cloudiness of the cornea.
Treatment is prescribed by the doctor, depending on the diagnosis. Clinical studies have shown that Taufon restores the functions of cell membranes, improves the transmission of nerve impulses, and activates metabolic processes. The drug has low absorption, which allows the therapeutic effect to accumulate without causing side effects.
Taufon is often prescribed in complex therapy, for example with Irifrin , Tsipromed, to correct spasm of accommodation. In such cases, vision improves noticeably after two weeks, but the recommended course of one month must be completed.
Methods of instillation and dosage
Treatment with Taufon, dose and course, depends on the disease. These eye drops can be used both as installations (they are dripped into the conjunctival sac) and subconjunctivally (injections). In some cases, it is also used orally (tablets). Usually, the prescription of treatment is very individual, taking into account the characteristics of the patient and the history of the disease. When using drops (even if prescribed by an ophthalmologist), be sure to read the instructions for use.
Important! Before instillation, the tube of medicine should be warmed to room temperature; to do this, just hold it in your hand.
- Use of Taufon for cataracts. Taufon drops are instilled into the conjunctival sac. The frequency depends on the doctor's prescription, but most often it is 3-4 times a day. Dose – 2-3 drops for each eye. The treatment period is 3 months with a break of 1 month, as well as a repeat course.
- If there has been an injury. Instill in the same doses (2-3 drops up to 4 times a day), but for 1 month. Sometimes the doctor may prescribe a shorter cycle.
- For open glaucoma. Here installations are carried out 2 times a day, 2-3 drops. Be sure to take it in combination with Timololomi 30 minutes before. The treatment period is very individual and is determined by the ophthalmologist.
- If degenerative phenomena or penetrating injuries of the cornea are present. Administered by injection (subconjunctival), the amount of the drug is 0.3 ml. 4 percent solution. 1 time per day. Course – 10 days. Repeat cycle after 6 or more often 8 months.
You should also know a number of features of using Taufon.
- Taufon can be used in parallel with other eye drops, but the interval should be at least 15 minutes, preferably 20.
- When instilling these drops, you can put on the lenses no earlier than after 20 minutes (they may become cloudy from the medicine).
- The edge of the bottle should not come into contact with the cornea or other surfaces.
- Do not use drops if you have an allergic reaction to taurine.
- When using drops in combination with eye ointments, the ointments should be applied after instillation, with an interval of at least 20 minutes.
- You should be careful when driving, as the procedure may cause temporary blurred vision. In this case, it is necessary to start operating vehicles or machinery no earlier than half an hour after installation.
Contraindications to the use of Taufon drops
Among the contraindications to the use of Taufon, only allergic reactions have been identified, which can manifest as burning, increased lacrimation, and redness. As a rule, if these side effects occur, the dose of the drug should be reduced.
The drug itself usually does not cause any discomfort and is well tolerated.
Cases of overdose have not been described.
Storage of Taufon drops
A special feature will be the mandatory storage of open packaging at a temperature not exceeding +15 0. A closed container can be stored for 3 years. After violation of sterility no more than 3 weeks.
Taufon eye drops should be used strictly as prescribed by your doctor.
Most often they are used to treat traumatic and degenerative phenomena on the retina and eye tissues; they effectively reduce the pressure of intraocular fluid, and in combination with Timolol and blood pressure. The medicine should not be used by persons under 18 years of age, pregnant women, or during lactation.
Taufon is an eye drop for restoring the retina. The drug is often used for glaucoma to normalize intraocular pressure. It has a retinoprotective and metabolic effect.
The active ingredient is taurine. Takes an active part in metabolic processes (especially fat), and also helps to optimize energy processes in the body.
Data from some experiments suggest that taurine plays the role of an amino acid responsible for the transmission of excitation in nerve tissues. It has an anticonvulsant effect, which can be used to achieve a cardiotropic effect.
Helps normalize the functions of cell membranes, activate energy and metabolic processes, preserve the electrolyte composition of the cytoplasm due to the accumulation of K+ and Ca2+, and improve the conditions for nerve impulse conduction.
Taufon eye drops stimulate regeneration processes in case of traumatic disorders of eye tissue and dystrophic changes in the retina.
Composition of Taufon drops (1 ml):
- taurine – 40 mg;
- auxiliary components: 1 M sodium hydroxide solution - up to pH 5.0–6.5, methylparaben (methyl parahydroxybenzoate) - 1 mg, water for injection - up to 1 ml.
special instructions
There is no data on changes in the effectiveness of Taufon after drinking alcohol.
The use of Taufon during pregnancy or lactation (breastfeeding) has no contraindications.
To avoid disruption of the transparency of soft contact lenses during the use of Taufon, it is recommended to remove them. You can use the lenses 30 minutes after instillation.
Release form: 5 ml of 4% solution in a bottle or 1 ml of solution in 1 ml ampoules with a solution of the same concentration. Tablets of 0.25 g - 60 or 100 per package (depending on the manufacturer).
The shelf life of the drug or analogues of Taufon after opening the bottle is up to 28 days in a dark, cool (temperature no higher than 15 0 C) place. The total shelf life of the bottle is up to 3 years.
Dispensed from the pharmacy without a prescription.
LS-001210-120911
Tradename:
Taufon.
International nonproprietary name:
Taurine.
Chemical name:
2-Aminoethanesulfonic acid.
Dosage form:
eye drops.
Compound:
1 ml of solution contains: Active substance:
taurine - 40 mg
Excipients:
methyl parahydroxybenzoate (methylparaben) - 1 mg 1 M sodium hydroxide solution to pH 5.0 - 6.5 water for injection up to 1 ml
Description:
transparent colorless liquid.
Pharmacotherapeutic group:
metabolic agent
ATX code:
S01XA.
Pharmacological properties:
Taurine is a sulfur-containing amino acid formed in the body during the conversion of cysteine.
Stimulates repair and regeneration processes in diseases of a dystrophic nature and diseases accompanied by a sharp disturbance in the metabolism of eye tissue. Helps normalize the functions of cell membranes, activate energy and metabolic processes, preserve the electrolyte composition of the cytoplasm due to the accumulation of K + and Ca 2+, and improve the conditions for nerve impulse conduction. Pharmacokinetics:
When applied topically, systemic absorption is low.
Indications for use:
The drug is prescribed to adults for:
- Corneal dystrophies;
- Senile, traumatic, radiation and other types of cataracts;
- Corneal injuries (as a stimulator of reparative processes);
- Primary open-angle glaucoma in combination with β-blockers (to improve the outflow of aqueous humor). For all indications, the drug is used as part of complex therapy.
Contraindications:
Individual hypersensitivity to taurine, children under 18 years of age. Use during pregnancy and breastfeeding:
There is no sufficient experience with the use of the drug during pregnancy and breastfeeding. It is possible to use Taufon for the treatment of pregnant and nursing mothers as prescribed by the attending physician, if the expected therapeutic effect exceeds the risk of developing possible side effects.Directions for use and dosage:
For cataracts, Taufon is prescribed in the form of installations of 1-2 drops 2-4 times a day for three months. The course is repeated at monthly intervals. For injuries and dystrophic diseases of the cornea, it is used in the same doses for one month. For open-angle glaucoma (in combination with butylaminohydroxypropoxyphenoxymethyl methyloxadiazole and its combined forms or timolol) - 1-2 drops 2 times a day, 15-20 minutes before prescribing one of the antihypertensive drugs, for 6 weeks, followed by cancellation for 2 weeks.
Side effect:
allergic reactions. If the side effects indicated in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor.
Overdose:
There are no data on overdose.
Interaction with other drugs:
In patients with glaucoma (open-angle), a significant increase in the hypotensive effect of β-blockers (timolol and butylaminohydroxypropoxyphenoxymethyl methyloxadiazole) was noted when used together with Taufon. The effect is enhanced by increasing the coefficient of ease of outflow and reducing the production of aqueous humor.
Release form:
Eye drops 4%. 1.5 ml, 2 ml or 5 ml in a polymer dropper tube. 1,2,4,5 or 10 dropper tubes with instructions for use of the drug and instructions for use of the dropper tube in a cardboard pack with or without partitions. 5 ml or 10 ml in a polymer dropper bottle. 1 or 2 dropper bottles with instructions for use of the drug and instructions for use of the dropper bottle in a cardboard pack. 5 ml in glass bottles. 1 bottle complete with a sterile dropper cap and instructions for use of the drug in a cardboard pack. 5 bottles in a blister pack made of polyvinyl chloride film. 1 blister pack complete with 5 sterile dropper caps and instructions for use of the drug in a cardboard pack.
Storage conditions:
At a temperature not exceeding 15 ° C, in a place protected from light, out of reach of children.
Best before date:
2 years in tube droppers and bottle droppers. 4 years in bottles. After opening - 1 month. Do not use after the expiration date stated on the packaging. Dispensing conditions:
Without a prescription.
Owner of the registration certificate/organization accepting the claims:
Federal State Unitary Enterprise "Moscow Endocrine Plant", 109052, Moscow, st. Novokhokhlovskaya, 25.Manufacturer:
Federal State Unitary Enterprise "Moscow Endocrine Plant".
Taufon eye drops are used to treat eye diseases associated with metabolic disorders in the cells of the cornea and internal tissues, as well as, if necessary, to stimulate the reparative (restorative and healing) abilities of cells during degenerative changes in tissues.
The composition of Taufon is a single preparation of taurine, the density of which in solution is 4%, as well as water.
Taurine is a sulfur-containing amino acid that is formed in our body from cysteine during complex transformation processes. In medicine, it is used in many preparations for the treatment of eyes.